Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mouse nerve growth factor for provisional intellectual developmental disorder in children
ChiCTR2000032886Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Anhui Medical University
- Start
- May 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of mouse nerve growth factor in disorder of intellectual development, provisional (PIDD) (2 arms), sponsored by First Affiliated Hospital of Anhui Medical University. Primary endpoint: Gesell Development Diagnosis Schedules. Planned start May 2020; status: not yet recruiting.
02
Drugs
mouse nerve growth factor
03
Conditions
disorder of intellectual development, provisional (PIDD)
Beyond the preview
Go deeper on ChiCTR2000032886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000032886.